Paper8096066
Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection.
Small PM and 7 others. N Engl J Med, 1993. Cited by 436 papers, by iCite.
Cite this record
ConductScience Library. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. Papers, record 8096066. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8096066
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| AIDS-Related Opportunistic Infections | Major topic |
| Antitubercular Agents | Major topic |
| Mycobacterium tuberculosis | Major topic |
| Tuberculosis, Pulmonary | Major topic |
| Adult | |
| DNA, Bacterial | |
| Drug Resistance, Microbial | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Polymorphism, Restriction Fragment Length | |
| Recurrence |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI07089-11 | NIAID NIH HHS | United States | PubMed | PubMed | |
| AI27762-03 | NIAID NIH HHS | United States | PubMed | PubMed | |
| P30AI027762 | NIH | NIH RePORTER | |||
| T32AI007089 | NIH | NIH RePORTER |
Comments and corrections3
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 8350906 | Reinfection with multidrug-resistant tuberculosis. | https://conductscience.org/library/papers/8350906 | PubMed |
| Comment in | 8350907 | Reinfection with multidrug-resistant tuberculosis. | https://conductscience.org/library/papers/8350907 | PubMed |
| Comment in | 8455687 | A tale of two mutants. | https://conductscience.org/library/papers/8455687 | PubMed |
Cited by111
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 436 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40406648 | Tuberculosis Trends in the Post-COVID-19 Era: Is It Going to be a Global Concern? | Health Sci Rep | 2025 | https://conductscience.org/library/papers/40406648 | PubMed |
| 36966312 | In silico characterization of cysteine-stabilized αβ defensins from neglected unicellular microeukaryotes. | BMC Microbiol | 2023 | https://conductscience.org/library/papers/36966312 | PubMed |
| 31720407 | Molecular genotyping to differentiate endogenous reactivation and exogenous reinfection of recurrent tuberculosis. | J Clin Tuberc Other Mycobact Dis | 2018 | https://conductscience.org/library/papers/31720407 | PubMed |
| 31233535 | Genetic diversity and drug susceptibility profiles of Mycobacterium tuberculosis obtained from Saint Peter's TB specialized Hospital, Ethiopia. | PLoS One | 2019 | https://conductscience.org/library/papers/31233535 | PubMed |
| 30730960 | Molecular drug susceptibility testing and strain typing of tuberculosis by DNA hybridization. | PLoS One | 2019 | https://conductscience.org/library/papers/30730960 | PubMed |
| 30554996 | Transmission of drug-resistant tuberculosis in HIV-endemic settings. | Lancet Infect Dis | 2019 | https://conductscience.org/library/papers/30554996 | PubMed |
| 29649213 | New insights into the transposition mechanisms of IS6110 and its dynamic distribution between Mycobacterium tuberculosis Complex lineages. | PLoS Genet | 2018 | https://conductscience.org/library/papers/29649213 | PubMed |
| 28790676 | PREVALENCE OF DRUG RESISTANT TUBERCULOSIS IN ARMED FORCES-STUDY FROM A TERTIARY REFERRAL CHEST DISEASES HOSPITAL AT PUNE. | Med J Armed Forces India | 2000 | https://conductscience.org/library/papers/28790676 | PubMed |
| 27688532 | Resistance to Antituberculosis Drugs in Pulmonary Tuberculosis. | Med J Armed Forces India | 2006 | https://conductscience.org/library/papers/27688532 | PubMed |
| 27516382 | Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. | Clin Infect Dis | 2016 | https://conductscience.org/library/papers/27516382 | PubMed |
| 27502557 | Impact of HIV co-infection on the evolution and transmission of multidrug-resistant tuberculosis. | Elife | 2016 | https://conductscience.org/library/papers/27502557 | PubMed |
| 27382565 | Comparative Analysis of Human B Cell Epitopes Based on BCG Genomes. | Biomed Res Int | 2016 | https://conductscience.org/library/papers/27382565 | PubMed |
| 26504253 | Foreign-Born Status and Geographic Patterns of Tuberculosis Genotypes in Tarrant County, Texas. | Prof Geogr | 2007 | https://conductscience.org/library/papers/26504253 | PubMed |
| 25300708 | Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss. | BMC Infect Dis | 2014 | https://conductscience.org/library/papers/25300708 | PubMed |
| 25190252 | Diversity and evolution of Mycobacterium tuberculosis: moving to whole-genome-based approaches. | Cold Spring Harb Perspect Med | 2014 | https://conductscience.org/library/papers/25190252 | PubMed |
| 24454706 | Potential cost-effectiveness of a new infant tuberculosis vaccine in South Africa--implications for clinical trials: a decision analysis. | PLoS One | 2014 | https://conductscience.org/library/papers/24454706 | PubMed |
| 23640554 | Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium. | Indian J Med Res | 2013 | https://conductscience.org/library/papers/23640554 | PubMed |
| 23555576 | A broad profile of co-dominant epitopes shapes the peripheral Mycobacterium tuberculosis specific CD8+ T-cell immune response in South African patients with active tuberculosis. | PLoS One | 2013 | https://conductscience.org/library/papers/23555576 | PubMed |
| 23223590 | Antituberculosis drug resistance acquired during treatment: an analysis of cases reported in California, 1994-2006. | Clin Infect Dis | 2013 | https://conductscience.org/library/papers/23223590 | PubMed |
| 23145087 | HIV-prevalence in tuberculosis patients in Germany, 2002-2009: an estimation based on HIV and tuberculosis surveillance data. | PLoS One | 2012 | https://conductscience.org/library/papers/23145087 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8096066
GET https://conductscience.org/api/papers/v1/8096066/cited_by?page=2